The gut microbiota resistome provides development of drug resistance in causative agents of human infectious diseases

  • E. N. Ilyina Federal State Budgetary Institution "Federal Scientific and Clinical Center for Physical and Chemical Medicine" of the Federal Medical and Biological Agency, Moscow, Russia
  • E. I. Olekhnovich Federal State Budgetary Institution "Federal Scientific and Clinical Center for Physical and Chemical Medicine" of the Federal Medical and Biological Agency, Moscow, Russia
  • A. V. Pavlenko Federal State Budgetary Institution "Federal Scientific and Clinical Center for Physical and Chemical Medicine" of the Federal Medical and Biological Agency, Moscow, Russia
Keywords: resistance to antibiotics, antibacterial drugs, microbiota, resistome, resistance potential

Abstract

Over the time, studies of antibiotic resistance have transformed from focusing on pathogenic microorganisms isolated as a pure culture to analysis of resistance at the level of microbial communities that constitute human and environmental biotopes. Advancing studies of antibiotic resistance require an integrated approach to enhance availability of information about observed tendencies in this field to the global community. It becomes increasingly obvious that, even though not all resistance genes can geographically and phylogenetically spread, the threat they pose is indeed serious and requires complex interdisciplinary research. Currently, the antibiotic resistance of human pathogens has become a challenge to modern medicine, which is now focusing on determining a potential source for bacterial genes of drug resistance and mechanisms for the gene transmission. In this review, we discussed problems generated by the widespread use of antibacterial drugs in the light of forming a reservoir of resistance genes by gut microflora.

Published
2017-07-28
How to Cite
Ilyina, E. N., Olekhnovich, E. I., & Pavlenko, A. V. (2017). The gut microbiota resistome provides development of drug resistance in causative agents of human infectious diseases. Patogenez (Pathogenesis), 15(3), 20-32. Retrieved from https://pathogenesis.pro/article/view/132